Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice E Chin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Drug Discovery & Development|September 28, 2006
Galanin function in the central nervous systemKevin M Walton, Janice E Chin, Allen J Duplantier, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 8, 2010
A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeysJanice D Wagner, Li Zhang, Kylie Kavanagh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2020
PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNAMatthias R Lambert, Janelle M Spinazzola, Jeffrey J Widrick, et al.
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial librariesAllyn T Londregan, David W Piotrowski, Kentaro Futatsugi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case ExampleMarkus Boehm, David Hepworth, Paula M Loria, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesityRichard L Elliott, Kimberly O Cameron, Janice E Chin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 AgonistsDavid W Piotrowski, Kentaro Futatsugi, Joseph S Warmus, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|September 28, 2006
Galanin function in the central nervous systemKevin M Walton, Janice E Chin, Allen J Duplantier, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 8, 2010
A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeysJanice D Wagner, Li Zhang, Kylie Kavanagh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2020
PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNAMatthias R Lambert, Janelle M Spinazzola, Jeffrey J Widrick, et al.
Bioorganic & Medicinal Chemistry Letters|January 23, 2013
Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial librariesAllyn T Londregan, David W Piotrowski, Kentaro Futatsugi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case ExampleMarkus Boehm, David Hepworth, Paula M Loria, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesityRichard L Elliott, Kimberly O Cameron, Janice E Chin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 AgonistsDavid W Piotrowski, Kentaro Futatsugi, Joseph S Warmus, et al.
Pageof 1